179 related articles for article (PubMed ID: 15128066)
21. Combination therapy with an immunomodulator and anti-TNFα agent improves bone mineral density in IBD patients.
Krajcovicova A; Hlavaty T; Killinger Z; Miznerova E; Toth J; Letkovsky J; Nevidanska M; Cierny D; Koller T; Zelinkova Z; Huorka M; Payer J
J Crohns Colitis; 2014 Dec; 8(12):1693-701. PubMed ID: 25175812
[TBL] [Abstract][Full Text] [Related]
22. Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.
Zhang Y; Milojevic D
Paediatr Drugs; 2017 Jun; 19(3):193-211. PubMed ID: 28290112
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.
Vestergaard P
Minerva Med; 2004 Dec; 95(6):469-80. PubMed ID: 15785432
[TBL] [Abstract][Full Text] [Related]
24. A 2008 panorama on osteoporosis and inflammatory bowel disease.
Sapone N; Pellicano R; Simondi D; Sguazzini C; Reggiani S; Terzi E; Rizzetto M; Astegiano M
Minerva Med; 2008 Feb; 99(1):65-71. PubMed ID: 18299697
[TBL] [Abstract][Full Text] [Related]
25. Analysis of risk factors for low bone mineral density in inflammatory bowel disease.
Frei P; Fried M; Hungerbuhler V; Rammert C; Rousson V; Kullak-Ublick GA
Digestion; 2006; 73(1):40-6. PubMed ID: 16543736
[TBL] [Abstract][Full Text] [Related]
26. Pediatric-onset inflammatory bowel disease poses risk for low bone mineral density at early adulthood.
Guz-Mark A; Rinawi F; Egotubov O; Shimon I; Shamir R; Assa A
Dig Liver Dis; 2017 Jun; 49(6):639-642. PubMed ID: 28179094
[TBL] [Abstract][Full Text] [Related]
27. Management of bone loss in inflammatory bowel disease.
Lichtenstein GR
Semin Gastrointest Dis; 2001 Oct; 12(4):275-83. PubMed ID: 11726081
[TBL] [Abstract][Full Text] [Related]
28. Examination, prevention and treatment of osteoporosis in patients with inflammatory bowel disease: recommendations and reality.
Kirchgatterer A; Wenzl HH; Aschl G; Hinterreiter M; Stadler B; Hinterleitner TA; Petritsch W; Knoflach P
Acta Med Austriaca; 2002; 29(4):120-3. PubMed ID: 12424936
[TBL] [Abstract][Full Text] [Related]
29. Osteoporosis in inflammatory bowel disease.
Compston J
Gut; 2003 Jan; 52(1):63-4. PubMed ID: 12477761
[No Abstract] [Full Text] [Related]
30. Risk Factors for Low Bone Density in Inflammatory Bowel Disease: Use of Glucocorticoids, Low Body Mass Index, and Smoking.
Even Dar R; Mazor Y; Karban A; Ish-Shalom S; Segal E
Dig Dis; 2019; 37(4):284-290. PubMed ID: 30799399
[TBL] [Abstract][Full Text] [Related]
31. [The decrease in bone density in chronic inflammatory bowel disease: prevalence and risk factors].
Trabelsi AB; Abdellaoui F; Ksiaa M; Souguir A; Zeglaoui H; Ben Rejeb M; Brahem A; Ajmi S; Jmaa A
Pan Afr Med J; 2013; 15():70. PubMed ID: 24198872
[TBL] [Abstract][Full Text] [Related]
32. Perspectives on osteoporosis in pediatric inflammatory bowel disease.
Harpavat M; Keljo DJ
Curr Gastroenterol Rep; 2003 Jun; 5(3):225-32. PubMed ID: 12734045
[TBL] [Abstract][Full Text] [Related]
33. Do Only Calcium and Vitamin D Matter? Micronutrients in the Diet of Inflammatory Bowel Diseases Patients and the Risk of Osteoporosis.
Ratajczak AE; Rychter AM; Zawada A; Dobrowolska A; Krela-Kaźmierczak I
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33562891
[TBL] [Abstract][Full Text] [Related]
34. Bone mineral density in patients with inflammatory bowel disease from north-eastern Romania.
Dumitrescu G; Mihai C; Dranga M; Prelipcean CC
Rev Med Chir Soc Med Nat Iasi; 2013; 117(1):23-8. PubMed ID: 24505888
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for low bone mineral density in pediatric inflammatory bowel disease: the positive role of physical activity.
Nobile S; Grand RJ; Pappa HM
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):471-476. PubMed ID: 29438136
[TBL] [Abstract][Full Text] [Related]
36. Nutrients in the Prevention of Osteoporosis in Patients with Inflammatory Bowel Diseases.
Ratajczak AE; Rychter AM; Zawada A; Dobrowolska A; Krela-Kaźmierczak I
Nutrients; 2020 Jun; 12(6):. PubMed ID: 32517239
[TBL] [Abstract][Full Text] [Related]
37. Increased fracture risk and osteoporosis not associated with vitamin D levels in Malaysian patients with inflammatory bowel disease.
Hilmi I; Sunderesvaran K; Ananda V; Sarji SA; Arumugam K; Goh KL
J Clin Endocrinol Metab; 2013 Jun; 98(6):2415-21. PubMed ID: 23553858
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory bowel disease and the risk of osteoporosis and fracture.
Targownik LE; Bernstein CN; Leslie WD
Maturitas; 2013 Dec; 76(4):315-9. PubMed ID: 24139749
[TBL] [Abstract][Full Text] [Related]
39. Basic and clinical aspects of osteoporosis in inflammatory bowel disease.
Rodríguez-Bores L; Barahona-Garrido J; Yamamoto-Furusho JK
World J Gastroenterol; 2007 Dec; 13(46):6156-65. PubMed ID: 18069754
[TBL] [Abstract][Full Text] [Related]
40. [Bone loss owing to inflammatory bowel disease: prospective study, 50 cases].
Ben Hamida KS; Serghini M; Ksontini I; Kedadi H; Ben Yaghléne L; Bougassas W; Dougui MH
Tunis Med; 2009 Feb; 87(2):144-8. PubMed ID: 19522449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
